GSE139178 GDC-0068 3 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE139178_GDC-0068_3_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE139178_GDC-0068_3_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE139178_GDC-0068_3_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE139178_GDC-0068_3_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

THAP9 antisense RNA 1

Gene

long intergenic non-protein coding RNA 665

Gene

long intergenic non-protein coding RNA 2910

Gene

zinc finger protein 883

Gene

ribosomal protein S2 pseudogene 5

Gene

zinc finger protein 702, pseudogene

Gene

deleted in lymphocytic leukemia 2

Gene

long intergenic non-protein coding RNA 869

Gene

colorectal cancer associated 1

Gene

ELFN1 antisense RNA 1

  • Gene

    THAP9 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    long intergenic non-protein coding RNA 2910


  • Gene

    zinc finger protein 883


  • Gene

    ribosomal protein S2 pseudogene 5


  • Gene

    zinc finger protein 702, pseudogene


  • Gene

    deleted in lymphocytic leukemia 2


  • Gene

    long intergenic non-protein coding RNA 869


  • Gene

    colorectal cancer associated 1


  • Gene

    ELFN1 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.